Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,048 | 45 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,201 | 37 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $231.81 | 2 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $124.86 | 1 | $0 (2022) |
| Gilead Sciences, Inc. | $124.73 | 1 | $0 (2019) |
| Medical Device Business Services, Inc. | $116.50 | 1 | $0 (2019) |
| Janssen Scientific Affairs, LLC | $108.14 | 1 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $99.94 | 1 | $0 (2019) |
| Sandoz Inc. | $41.14 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $90.61 | 1 | ABBVIE INC. ($90.61) |
| 2023 | $287.87 | 4 | AbbVie Inc. ($246.73) |
| 2022 | $304.88 | 4 | ABBVIE INC. ($180.02) |
| 2021 | $266.95 | 3 | AbbVie Inc. ($266.95) |
| 2020 | $357.81 | 5 | AbbVie Inc. ($243.21) |
| 2019 | $832.42 | 11 | AbbVie, Inc. ($491.25) |
| 2018 | $675.61 | 14 | AbbVie, Inc. ($567.47) |
| 2017 | $231.96 | 3 | Merck Sharp & Dohme Corporation ($117.21) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/10/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $90.61 | General |
| 06/13/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $111.74 | General |
| 06/13/2023 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $29.36 | General |
| Category: VIROLOGY | ||||||
| 04/11/2023 | Sandoz Inc. | — | Food and Beverage | In-kind items and services | $41.14 | General |
| 02/22/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $105.63 | General |
| 07/27/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $89.28 | General |
| Category: IMMUNOLOGY | ||||||
| 07/21/2022 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $124.86 | General |
| Category: Neuroscience | ||||||
| 06/30/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.02 | General |
| Category: IMMUNOLOGY | ||||||
| 02/10/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $62.72 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2021 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $82.20 | General |
| 08/05/2021 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $108.53 | General |
| 05/11/2021 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $76.22 | General |
| 10/21/2020 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $101.80 | General |
| 09/22/2020 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $85.82 | General |
| 03/12/2020 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $28.69 | General |
| 03/12/2020 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $26.90 | General |
| 02/05/2020 | Merck Sharp & Dohme Corporation | ZINPLAVA (Biological) | Food and Beverage | In-kind items and services | $114.60 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/16/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $71.28 | General |
| 11/12/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $110.11 | General |
| 11/08/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $33.93 | General |
| 08/20/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $99.94 | General |
| 08/08/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $35.15 | General |
| 07/10/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $124.73 | General |
| 04/04/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $57.26 | General |
| 03/05/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $48.12 | General |
About Dr. Philip Styne, M.D
Dr. Philip Styne, M.D is a Gastroenterology healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265471502.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Philip Styne, M.D has received a total of $3,048 in payments from pharmaceutical and medical device companies, with $90.61 received in 2024. These payments were reported across 45 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($3,048).
Practice Information
- Specialty Gastroenterology
- Location Orlando, FL
- Active Since 06/05/2006
- Last Updated 04/29/2014
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1265471502
Products in Payments
- ZINPLAVA (Biological) $231.81
- RINVOQ (Biological) $180.02
- ZEPOSIA (Drug) $124.86
- Mavyret (Drug) $122.31
- LINX Reflux Management System (Device) $116.50
- STELARA (Biological) $108.14
- Humira (Biological) $100.00
- MAVYRET (Drug) $29.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Orlando
Dr. Samuel Giday, M.d, M.D
Gastroenterology — Payments: $2.6M
Jennifer Seminerio-Diehl, Md, MD
Gastroenterology — Payments: $814,283
Dr. Robert Hawes, Md, MD
Gastroenterology — Payments: $593,475
Muhammad Hasan, Md, MD
Gastroenterology — Payments: $261,176
Dr. Kenneth Feuer, Md, MD
Gastroenterology — Payments: $142,471
Dr. Natalie Cosgrove, Md, MD
Gastroenterology — Payments: $132,710